Type 1 diabetes (T1D) is an autoimmune disease in which the body’s immune system destroys the cells in the pancreas that produce insulin. The disease most commonly starts in childhood but can develop in adults […]
Denver metropolitan students can pursue careers in sonography and ultrasound, through Concorde’s DMS associate degree program AURORA, Colo., Feb. 28, 2023 /PRNewswire/ — Concorde Career Colleges, Inc., the health care division of Universal Technical Institute, […]
LOUISVILLE, Colo.–(BUSINESS WIRE)–Sierra Space, a leading pureplay commercial space company building the first end-to-end business and technology platform in space, announced today the signing of a Memorandum of Understanding (MOU) with the University of Notre […]
Type 1 diabetes (T1D) is an autoimmune disease in which the body’s immune system destroys the cells in the pancreas that produce insulin. The disease most commonly starts in childhood but can develop in adults […]
On February 6, 2023, the federal Help Ensure Lower Patient (HELP) Copays Act (H.R. 830) was reintroduced in the U.S. House of Representatives by Representative Earl “Buddy” Carter (R-GA) and referred to the House Committee on […]
It’s a fact. Health disparities exist across all levels of the healthcare system. Kamal Henderson, MD, assistant professor, Division of Cardiology, takes a pragmatic approach to his work in the clinic and his research. He’s […]
One dozen Democrat attorneys general are suing the FDA in federal court in the eastern district of Washington to remove all restrictions on mifepristone, a pill used in combination with another medicine to end early […]
Not long after Colorado legalized marijuana for recreational use in 2012, Lori Walker’s daughter came home shaken from a party. “Mom, what does pot do to the heart?” she asked Walker, PhD, an associate professor […]
Editor’s Note: The joint efforts of the Gates Institute, Children’s Hospital Colorado, and the University of Colorado School of Medicine elevate the research, innovation and care for Ehlers-Danlos Syndrome (EDS), a collection of difficult-to-treat and […]
A US and Dutch biotech closed its $40 million Series A to bankroll more studies of its oral anti-inflammatory drug. Olatec Therapeutics said the financing will fund a late-stage clinical trial of its drug, dapansutrile, an NLRP3 […]
Copyright © Biotech Networks 2022
